Resources for Your Health
Comprehensive information about the TULSA Procedure, recovery, and outcomes. Learn from our experts and make informed decisions about your prostate cancer care.
ABC Evening News interviews Dr. Hong with TULSA patient Albert Lopez
Dr. Hong Talks TULSA on Good Morning Arizona with Scott Pasmore
More Stories
Every patient's journey is unique, but they all share one thing: hope restored
Learning Center
Explore detailed educational materials about TULSA-PRO treatment, including how the procedure works, what to expect during recovery, and real patient outcomes.
- How TULSA-PRO Works
- Treatment Process Overview
- Recovery Timeline
- Clinical Outcomes & Data
"Dr. Hong's unwavering dedication led to remarkable results."
Blog
Read the latest articles and insights from Dr. Hong and our team about prostate cancer treatment, patient stories, and advances in minimally invasive procedures.
- Expert Insights
- Patient Stories
- Medical Updates
- Treatment Advances
"We feared the side effects of traditional surgery. TULSA-PRO gave us a better option."
Frequently Asked Questions
Get answers to common questions about the TULSA Procedure treatment, recovery, and outcomes. Browse by category or search for specific information.
Browse by Category
- All
- Treatment
- Recovery
- Procedure
- Insurance
- Cost
- Candidacy
- Outcomes
Is TULSA-PRO FDA authorized for use?
Treatment
Yes. TULSA-PRO received FDA clearance for the treatment of prostate tissue.
Clearance and approval are both forms of FDA authorization, granted through different review pathways depending on the type of device. That clearance is based on a review of the device's safety and effectiveness data by the FDA.
Dr. Hong has personally performed 250+ procedures using this cleared technology since bringing it to Arizona.
How long is recovery?
Recovery
Most patients return to normal activity within days and feel fully recovered within two weeks. The minimally invasive nature of TULSA-PROTM means significantly shorter recovery times compared to traditional surgical approaches.
Will I need a catheter?
Procedure
Yes, temporarily. Most patients describe it as manageable and short-term. The catheter is typically removed within a few days to weeks, and patients can resume normal activities shortly after.
Is the procedure covered by insurance?
Insurance
Pre- and post-procedure care is often covered. The procedure itself is self-pay. We recommend contacting your insurance provider to understand your specific coverage and benefits.
Is it worth the cost?
Cost
Patients consistently tell us the outcome—health, confidence, peace of mind—was priceless, and the investment in their health and quality of life was invaluable.
Who is a good candidate for TULSA-PRO?
Candidacy
Candidates are typically men with localized prostate cancer who want to preserve sexual function and bladder control. Dr. Hong performs a detailed MRI review to confirm candidacy for each patient.
What are the success rates?
Outcomes
TULSA-PRO has demonstrated strong outcomes in clinical data: up to 98% erectile function preservation in focal ablation patients at 1–2 years (76% for whole-gland treatment), and ~95% average PSA reduction.
For comparison, radical prostatectomy preserves erectile function in an estimated 30–70% of men, and radiation in 40–60% — every patient's outcome depends on individual factors like cancer stage, prostate anatomy, and treatment approach, which Dr. Hong reviews in detail during consultation.
How is TULSA-PRO different from other treatments?
Procedure
TULSA-PROTM is the only MRI-guided, whole-gland-enabled ablation therapy. Other minimally-invasive treatments are focal only or do not utilize MRI-precision. TULSA-PROTM combines precision with minimal invasiveness, offering superior outcomes for sexual function and continence compared to surgery or radiation.
Bibliography
1. https://finance.yahoo.com/news/profound-medical-celebrates-hong-center-211500339.html
2. Klotz, et al. "Magnetic Resonance Imaging-Guided Transurethral Ultrasound Ablation of Prostate Cancer" The Journal of Urology (2021)
3. Ehdaie, et al. "MRI-guided focused ultrasound focal therapy for patients with intermediate-risk prostate cancer: a phase 2b, multicentre study." Lancet Oncology (2022)
4. Ghai, et al. New kids on the block: MRI guided transrectal focused US, TULSA, focal laser ablation, histotripsy – a comprehensive review. Prostate Cancer and Prostatic Diseases (2025)
5. Hong YM. "Transurethral Ultrasound Ablation Procedure vs Robotic-Assisted Laparoscopic Radical Prostatectomy." American Urological Association News (2024)
TULSA-PRO vs. Robotic Prostatectomy Clinical Trials
1. https://www.urotoday.com/conference-highlights/eau-2026/eau-2026-prostate-cancer/167379-eau-2026-captain-randomized-controlled-trial-evaluating-mri-guided-tulsa-versus-robotic-prostatectomy-initial-perioperative-outcomes.html
2. https://www.sciencedirect.com/science/article/abs/pii/S1078143924009803
3. https://pubmed.ncbi.nlm.nih.gov/33021440/
Ready to Learn More?
Schedule a private consultation with Dr. Hong to discuss your prostate cancer treatment options and determine if TULSA-PROTM is right for you.